Corporate Business Development

“Wyeth's success over time has been greatly augmented by a number of outstanding product alliances. We tailor our partnerships toward the optimal combination of the unique strengths and capabilities of both partners. Wyeth contributes industry-leading expertise in research, development, manufacturing, and global commercialization across its three technology platforms: small molecules, biopharmaceuticals, and vaccines.”
Bernard Poussot, President and CEO, Wyeth